Matt received his BA in Biology from the University of Utah. He got his start at the Huntsman Cancer Institute (HCI) during his undergraduate studies where he worked on understanding IDH mutations in glioma. After graduating he spent 2 more years at HCI studying small cell lung cancer with an emphasis on understanding mechanisms of disease progression and identifying novel therapeutic strategies. Outside of work, Matt enjoys spending time with his friends and family, hiking, and traveling.
Are you Recursion ready?
Join our passionate, innovative team—and help us realize our goal of 100 treatments by 2025.